Kendra Orjada

Bio:

Kendra brings more than 23 years of experience leading cross‑functional programs across the life sciences and regulatory landscape. For 16 years, she served as a consultant at Booz Allen Hamilton, supporting major federal health agencies including the FDA, NIH, and the Defense Health Agency. In this role, she guided pharmaceutical, biologics, and medical device initiatives on issues spanning regulatory oversight of clinical and health research, medical product development, and advanced manufacturing.

Before joining Booz Allen, Kendra worked at the EMMES Corporation as the lead regulatory analyst for the National Cancer Institute’s Central Institutional Review Board and as a protocol specialist for the National Institute on Drug Abuse’s Clinical Trials Network. She also held roles at the George Washington University Medical Center as an Institutional Review Board administrator and served as a lead research coordinator at both the University of Southern California and the University of Texas at Austin.
She holds an MPH from Johns Hopkins University and a BA from the University of Texas at Austin.